机译:在低甲基化试剂失效后,少于风险髓细胞增生综合征和慢性骨髓细胞白血病患者的Omacetaxine Mepescate的II期研究
Univ Texas MD Anderson Canc Ctr Dept Leukemia Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Leukemia Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Leukemia Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Leukemia Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Biostat Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Leukemia Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Biostat Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Leukemia Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Leukemia Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Leukemia Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Leukemia Houston TX 77030 USA;
Univ Texas Hlth Sci Ctr Houston Dept Internal Med Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Leukemia Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Leukemia Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Leukemia Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Leukemia Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Leukemia Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Leukemia Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Leukemia Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Leukemia Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Leukemia Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Leukemia Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Leukemia Houston TX 77030 USA;
机译:在低甲基化试剂失效后,少于风险髓细胞增生综合征和慢性骨髓细胞白血病患者的Omacetaxine Mepescate的II期研究
机译:瓜地西他滨(SGI-110)(一种新型皮下(sc)次甲基化剂)用于先前未治疗的中度2或高危骨髓增生异常综合征(MDS)或慢性粒细胞性白血病(CMML)的患者的2期研究的初步结果
机译:瓜地西他滨(SGI-110)(一种新型皮下(sc)次甲基化剂)用于先前未治疗的中度2或高危骨髓增生异常综合征(MDS)或慢性粒细胞性白血病(CMML)的患者的2期研究的初步结果
机译:竞争内源性RNA网络的分析及III期急性淋巴细胞白血病患者预后预测
机译:慢性骨髓衰竭和输血模式:骨髓增生综合征患者出血和结果的流行病学研究
机译:阿扎胞苷单独或与来那度胺或伏立诺他汀联合治疗高危骨髓增生异常综合征和慢性粒细胞性白血病的随机II期研究:北美小组研究SWOG S1117
机译:系统文献综述治疗方案和患有高风险骨髓增生综合征和慢性骨髓细胞白血病的患者的临床结果